Formulation of the Scope and Key Questions of the Guideline Recommendations for Immunosuppressive Treatment in Kidney Transplantation |
Huh, Seungyeon
(College of Pharmacy & Research Institute of Pharmaceutical Science, Seoul National University)
Han, Nayoung (College of Pharmacy & Research Institute of Pharmaceutical Science, Seoul National University) Sohn, Minji (College of Pharmacy & Research Institute of Pharmaceutical Science, Seoul National University) Ryu, Junghwa (Transplantation Center, Seoul National University Hospital) Yang, Jaeseok (Transplantation Center, Seoul National University Hospital) Oh, Jung Mi (College of Pharmacy & Research Institute of Pharmaceutical Science, Seoul National University) |
1 | BC Transplant Society. Clinical Guidelines for Kidney Transplantation [Internet]. Canada: Provincial Health Services Authority, c2018 [cited 2018 Dec 10]. Available from: http://www.transplant.bc.ca/health-professionals/transplant-clinical-guidelines/guidelines-for-transplant. |
2 | Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 2009;9 Suppl 3:S1-155. |
3 | Woolf S, Schünemann HJ, Eccles MP, et al. Developing clinical practice guidelines: types of evidence and outcomes; values and economics, synthesis, grading, and presentation and deriving recommendations. Implement Sci 2012;7:61. DOI |
4 | Port FK, Wolfe RA, Mauger EA, et al. Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients. JAMA 1993;270(11):1339-43. DOI |
5 | Kim SI, Kim YS, Kim MS, et al. A renal transplantation and hemodialysis cost-utility analysis in patients with end-stage renal disease. J Korean Soc Transplant 2010;24(3):173-81. DOI |
6 | Korean Network for Organ Sharing (KONOS). Annual report of the transplant 2017 [Internet]. Seoul (KR): Korean Network for Organ Sharing, c2018 [cited 2018 Dec 10]. Available from: http://www.konos.go.kr. |
7 | Kim SH, Jo MW, Go DS, et al. Economic burden of chronic kidney disease in Korea using national sample cohort. J Nephrol 2017;30(6):787-93. DOI |
8 | Legendre C, Canaud G, Martinez F. Factors influencing long-term outcome after kidney transplantation. Transpl Int 2014 Jan;27(1):19-27. DOI |
9 | Denton MD, Magee CC, Sayegh MH. Immunosuppressive strategies in transplantation. Lancet 1999;353(9158):1083-91. DOI |
10 | Kalluri HV and Hardinger KL. Current state of renal transplant immunosuppression: Present and future. World J Transplant 2012;2(4):51-68. DOI |
11 | Field MJ and Lohr KN. Clinical practice guideline: directions for a new program. Washington D.C.: National Academy Press 1990;8-18. |
12 | Yoon HE and Yang CW. Renal transplantation in highly sensitized recipients. J Korean Soc Transplant 2008;22:8-12. |
13 | Woolf SH, Grol R, Hutchinson A, et al. Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines. BMJ 1999;318(7182):527-30. DOI |
14 | Entwistle VA, Watt IS, Davis H, et al. Developing information materials to present the findings of technology assessments to consumers. The experience of the NHS Centre for Reviews and Dissemination. Int J Technol Assess Health Care 1998;14(1):47-70. DOI |
15 | Lee S and Kang DH. ABO-incompatible kidney transplantation. Ewha Med J 2015;38(1):7-13. DOI |
16 | Yu H, Kim YJ, Kwon SW, et al. ABO incompatible living donor kidney transplantation with rituximab and plasmapheresis: A single center experience. Korean J Nephrol 2011;30:386-93. |
17 | Karuthu S and Blumberg EA. Common infections in kidney transplant recipients. Clin J Am Soc Nephrol 2012;7(12):2058-70. DOI |
18 | Silkensen JR. Long-term complications in renal transplantation. J Am Soc Nephrol 2000;11(3):582-8. DOI |
19 | Baker RJ, Mark PB, Patel RK, et al. Renal association clinical practice guideline in post-operative care in the kidney transplant recipient. BMC Nephrol 2017;18(1):174. DOI |